Dendritic Cell-Based Vaccine Efficacy: Aiming for Hot Spots
Tóm tắt
Từ khóa
Tài liệu tham khảo
Madan, 2010, Therapeutic cancer vaccines in prostate cancer: the paradox of improved survival without changes in time to progression, Oncologist, 15, 969, 10.1634/theoncologist.2010-0129
Guo, 2013, Therapeutic cancer vaccines: past, present, and future, Adv Cancer Res, 119, 421, 10.1016/B978-0-12-407190-2.00007-1
Palucka, 2010, Dendritic cells: are they clinically relevant?, Cancer J, 16, 318, 10.1097/PPO.0b013e3181eaca83
Palucka, 2013, Dendritic-cell-based therapeutic cancer vaccines, Immunity, 39, 38, 10.1016/j.immuni.2013.07.004
Chen, 2013, Oncology meets immunology: the cancer-immunity cycle, Immunity, 39, 1, 10.1016/j.immuni.2013.07.012
Butterfield, 2013, Dendritic cells in cancer immunotherapy clinical trials: are we making progress?, Front Immunol, 4, 454, 10.3389/fimmu.2013.00454
Galluzzi, 2012, Trial watch: dendritic cell-based interventions for cancer therapy, Oncoimmunology, 1, 1111, 10.4161/onci.21494
Depillis, 2013, A model of dendritic cell therapy for melanoma, Front Oncol, 3, 56, 10.3389/fonc.2013.00056
Kalinski, 2011, Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?, Immunol Res, 50, 235, 10.1007/s12026-011-8224-z
Pinzon-Charry, 2005, Dendritic cell dysfunction in cancer: a mechanism for immunosuppression, Immunol Cell Biol, 83, 451, 10.1111/j.1440-1711.2005.01371.x
Herber, 2010, Lipid accumulation and dendritic cell dysfunction in cancer, Nat Med, 16, 880, 10.1038/nm.2172
Alters, 1999, IL-13 can substitute for IL-4 in the generation of dendritic cells for the induction of cytotoxic T lymphocytes and gene therapy, J Immunother, 22, 229, 10.1097/00002371-199905000-00005
Reichardt, 2010, APC, T cells, and the immune synapse, Curr Top Microbiol Immunol, 340, 229, 10.1007/978-3-642-03858-7_12
Linette, 2013, Dendritic cell-based vaccines: shining the spotlight on signal 3, Oncoimmunology, 2, e26512, 10.4161/onci.26512
Delamarre, 2011, Harnessing dendritic cells for immunotherapy, Semin Immunol, 23, 2, 10.1016/j.smim.2011.02.001
Frankenberger, 2012, Third generation dendritic cell vaccines for tumor immunotherapy, Eur J Cell Biol, 91, 53, 10.1016/j.ejcb.2011.01.012
Jonuleit, 1997, Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions, Eur J Immunol, 27, 3135, 10.1002/eji.1830271209
Boullart, 2008, Maturation of monocyte-derived dendritic cells with toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration, Cancer Immunol Immunother, 57, 1589, 10.1007/s00262-008-0489-2
Marongiu, 2013, ESAT-6 and HspX improve the effectiveness of BCG to induce human dendritic cells-dependent Th1 and NK cells activation, PLoS One, 8, e75684, 10.1371/journal.pone.0075684
Sheng, 2013, Enhanced dendritic cell-mediated antigen-specific CD4+ T cell responses: IFN-gamma aids TLR stimulation, J Drug Deliv, 2013, 516749, 10.1155/2013/516749
Mailliard, 2004, Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity, Cancer Res, 64, 5934, 10.1158/0008-5472.CAN-04-1261
Hansen, 2012, Cellular based cancer vaccines: type 1 polarization of dendritic cells, Curr Med Chem, 19, 4239, 10.2174/092986712802884213
Dauer, 2003, Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors, J Immunol, 170, 4069, 10.4049/jimmunol.170.8.4069
Spranger, 2010, Generation of Th1-polarizing dendritic cells using the TLR7/8 agonist CL075, J Immunol, 185, 738, 10.4049/jimmunol.1000060
Sparber, 2010, Langerhans cells and dermal dendritic cells capture protein antigens in the skin: possible targets for vaccination through the skin, Immunobiology, 215, 770, 10.1016/j.imbio.2010.05.014
Palucka, 2010, Designing vaccines based on biology of human dendritic cell subsets, Immunity, 33, 464, 10.1016/j.immuni.2010.10.007
Fehres, 2013, Skin-resident antigen-presenting cells: instruction manual for vaccine development, Front Immunol, 4, 157, 10.3389/fimmu.2013.00157
Hailemichael, 2013, Persistent antigen at vaccination sites induces tumor-specific CD8(+) T cell sequestration, dysfunction and deletion, Nat Med, 19, 465, 10.1038/nm.3105
Mullins, 2003, Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control, J Exp Med, 198, 1023, 10.1084/jem.20021348
Lesterhuis, 2011, Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients, Clin Cancer Res, 17, 5725, 10.1158/1078-0432.CCR-11-1261
Mahnke, 2000, The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments, J Cell Biol, 151, 673, 10.1083/jcb.151.3.673
Bonifaz, 2002, Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance, J Exp Med, 196, 1627, 10.1084/jem.20021598
Kreutz, 2012, Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity, PLoS One, 7, e40208, 10.1371/journal.pone.0040208
Bouvier, 2011, Immunization route dictates cross-priming efficiency and impacts the optimal timing of adjuvant delivery, Front Immunol, 2, 71, 10.3389/fimmu.2011.00071
Hangalapura, 2011, Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine, Vaccine, 29, 2313, 10.1016/j.vaccine.2011.01.022
Sen, 2010, Selective and site-specific mobilization of dermal dendritic cells and Langerhans cells by Th1- and Th2-polarizing adjuvants, Proc Natl Acad Sci U S A, 107, 8334, 10.1073/pnas.0912817107
Barrio, 2012, Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells, PLoS One, 7, e40311, 10.1371/journal.pone.0040311
Kim, 2012, Microneedles for drug and vaccine delivery, Adv Drug Deliv Rev, 64, 1547, 10.1016/j.addr.2012.04.005
Suh, 2014, Microneedle patches for vaccine delivery, Clin Exp Vaccine Res, 3, 42, 10.7774/cevr.2014.3.1.42
Zaric, 2013, Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses, ACS Nano, 7, 2042, 10.1021/nn304235j
Ohlfest, 2013, Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model, J Immunol, 190, 613, 10.4049/jimmunol.1201557
Lindenberg, 2013, IL-10 conditioning of human skin affects the distribution of migratory dendritic cell subsets and functional T cell differentiation, PLoS One, 8, e70237, 10.1371/journal.pone.0070237
Mac Keon, 2010, Vaccination with dendritic cells charged with apoptotic/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue, Vaccine, 28, 8162, 10.1016/j.vaccine.2010.09.095
Harris, 2012, The vaccine-site microenvironment induced by injection of incomplete Freund’s adjuvant, with or without melanoma peptides, J Immunother, 35, 78, 10.1097/CJI.0b013e31823731a4
Liu, 2014, In situ modulation of dendritic cells by injectable thermosensitive hydrogels for cancer vaccines in mice, Biomacromolecules, 15, 3836, 10.1021/bm501166j
Purwada, 2014, Engineering vaccines and niches for immune modulation, Acta Biomater, 10, 1728, 10.1016/j.actbio.2013.12.036
Bobanga, 2013, Chemokines as cancer vaccine adjuvants, Vaccines (Basel), 1, 444, 10.3390/vaccines1040444
Shih, 2009, Conditioning vaccination site with irradiated MIP-3alpha-transfected tumor cells enhances efficacy of dendritic cell-based cancer vaccine, J Immunother, 32, 363, 10.1097/CJI.0b013e31819d29d8
Herrlinger, 2004, MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model, J Neurooncol, 66, 147, 10.1023/B:NEON.0000013497.04322.fc
Gnjatic, 2010, Toll-like receptor agonists: are they good adjuvants?, Cancer J, 16, 382, 10.1097/PPO.0b013e3181eaca65
Perret, 2013, Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity, Cancer Res, 73, 6597, 10.1158/0008-5472.CAN-13-0875
Goldinger, 2012, Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8(+) T-cell responses in melanoma patients, Eur J Immunol, 42, 3049, 10.1002/eji.201142361
Bright, 2013, Injection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigen, Oncoimmunology, 2, e25049, 10.4161/onci.25049
Dang, 2012, Dendritic cell-activating vaccine adjuvants differ in the ability to elicit antitumor immunity due to an adjuvant-specific induction of immunosuppressive cells, Clin Cancer Res, 18, 3122, 10.1158/1078-0432.CCR-12-0113
Fehres, 2014, Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+ T-cell cross-priming, Eur J Immunol, 44, 2415, 10.1002/eji.201344094
Duewell, 2011, ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells, J Immunol, 187, 55, 10.4049/jimmunol.1004114
Castellino, 2006, Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction, Nature, 440, 890, 10.1038/nature04651
Munoz, 2014, T cell migration in intact lymph nodes in vivo, Curr Opin Cell Biol, 30C, 17, 10.1016/j.ceb.2014.05.002
Teijeira, 2014, Taking the lymphatic route: dendritic cell migration to draining lymph nodes, Semin Immunopathol, 36, 261, 10.1007/s00281-013-0410-8
Grayson, 2007, Controls for lung dendritic cell maturation and migration during respiratory viral infection, J Immunol, 179, 1438, 10.4049/jimmunol.179.3.1438
Miller, 2004, T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node, Proc Natl Acad Sci U S A, 101, 998, 10.1073/pnas.0306407101
Mandl, 2012, Quantification of lymph node transit times reveals differences in antigen surveillance strategies of naive CD4+ and CD8+ T cells, Proc Natl Acad Sci U S A, 109, 18036, 10.1073/pnas.1211717109
Kaiser, 2005, CC chemokine ligand 19 secreted by mature dendritic cells increases naive T cell scanning behavior and their response to rare cognate antigen, J Immunol, 175, 2349, 10.4049/jimmunol.175.4.2349
Bousso, 2003, Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes, Nat Immunol, 4, 579, 10.1038/ni928
Hugues, 2007, Dynamic imaging of chemokine-dependent CD8+ T cell help for CD8+ T cell responses, Nat Immunol, 8, 921, 10.1038/ni1495
de Vries, 2003, Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state, Cancer Res, 63, 12
Sanchez-Sanchez, 2006, The multiple personalities of the chemokine receptor CCR7 in dendritic cells, J Immunol, 176, 5153, 10.4049/jimmunol.176.9.5153
Chen, 2013, Co-transfection gene delivery of dendritic cells induced effective lymph node targeting and anti-tumor vaccination, Pharm Res, 30, 1502, 10.1007/s11095-013-0985-8
MartIn-Fontecha, 2003, Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming, J Exp Med, 198, 615, 10.1084/jem.20030448
Yin, 2014, Lymphatic specific disruption in the fine structure of heparan sulfate inhibits dendritic cell traffic and functional T cell responses in the lymph node, J Immunol, 192, 2133, 10.4049/jimmunol.1301286
Ratzinger, 2002, Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin, J Immunol, 168, 4361, 10.4049/jimmunol.168.9.4361
Johnson, 2014, Control of dendritic cell trafficking in lymphatics by chemokines, Angiogenesis, 17, 335, 10.1007/s10456-013-9407-0
Aarntzen, 2013, Targeting of 111In-labeled dendritic cell human vaccines improved by reducing number of cells, Clin Cancer Res, 19, 1525, 10.1158/1078-0432.CCR-12-1879
Verdijk, 2008, Maximizing dendritic cell migration in cancer immunotherapy, Expert Opin Biol Ther, 8, 865, 10.1517/14712598.8.7.865
Srinivas, 2010, Imaging of cellular therapies, Adv Drug Deliv Rev, 62, 1080, 10.1016/j.addr.2010.08.009
Ferguson, 2013, Using magnetic resonance imaging to evaluate dendritic cell-based vaccination, PLoS One, 8, e65318, 10.1371/journal.pone.0065318
Munn, 2006, The tumor-draining lymph node as an immune-privileged site, Immunol Rev, 213, 146, 10.1111/j.1600-065X.2006.00444.x
Zheng, 2011, Immune response to cancer and its regulation in regional lymph nodes, J Surg Oncol, 103, 550, 10.1002/jso.21692
Jeanbart, 2014, Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes, Cancer Immunol Res, 2, 436, 10.1158/2326-6066.CIR-14-0019-T
Boissonnas, 2010, Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes, Immunity, 32, 266, 10.1016/j.immuni.2009.11.015
Chang, 2013, Spatial organization of dendritic cells within tumor draining lymph nodes impacts clinical outcome in breast cancer patients, J Transl Med, 11, 242, 10.1186/1479-5876-11-242
van de Ven, 2011, Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation, Blood, 118, 2502, 10.1182/blood-2011-03-344838
St John, 2012, Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes, Nat Mater, 11, 250, 10.1038/nmat3222
Higham, 2010, Activation of tolerogenic dendritic cells in the tumor draining lymph nodes by CD8+ T cells engineered to express CD40 ligand, J Immunol, 184, 3394, 10.4049/jimmunol.0903111
Bouwer, 2014, NK cells are required for dendritic cell-based immunotherapy at the time of tumor challenge, J Immunol, 192, 2514, 10.4049/jimmunol.1202797
Wong, 2013, IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patients, Oncoimmunology, 2, e26245, 10.4161/onci.26245
Henrickson, 2013, Antigen availability determines CD8(+) T cell-dendritic cell interaction kinetics and memory fate decisions, Immunity, 39, 496, 10.1016/j.immuni.2013.08.034
Rosalia, 2013, Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation, Eur J Immunol, 43, 2554, 10.1002/eji.201343324
Wang, 2012, Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice, Breast Cancer Res, 14, R39, 10.1186/bcr3135
Pizzurro, 2013, High lipid content of irradiated human melanoma cells does not affect cytokine-matured dendritic cell function, Cancer Immunol Immunother, 62, 3, 10.1007/s00262-012-1295-4
Fox, 2013, TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses, Vaccine, 31, 5848, 10.1016/j.vaccine.2013.09.069
Welters, 2010, Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses, Proc Natl Acad Sci U S A, 107, 11895, 10.1073/pnas.1006500107
Valente, 2014, Apoptotic cell capture by DCs induces unexpectedly robust autologous CD4+ T-cell responses, Eur J Immunol, 44, 2274, 10.1002/eji.201344191
Church, 2014, Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells, Eur J Immunol, 44, 69, 10.1002/eji.201343718
Schiering, 2010, Antigen-experienced CD4(+) T cells limit naive T-cell priming in response to therapeutic vaccination in vivo, Cancer Res, 70, 6161, 10.1158/0008-5472.CAN-09-4398
Snook, 2014, Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy, Eur J Immunol, 44, 1956, 10.1002/eji.201444539
Aarntzen, 2013, Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination, Cancer Res, 73, 19, 10.1158/0008-5472.CAN-12-1127
Ahmadzadeh, 2009, Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired, Blood, 114, 1537, 10.1182/blood-2008-12-195792
Vasaturo, 2013, Clinical implications of co-inhibitory molecule expression in the tumor microenvironment for DC vaccination: a game of stop and go, Front Immunol, 4, 417, 10.3389/fimmu.2013.00417
Idorn, 2014, Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer, Cancer Immunol Immunother, 63, 1177, 10.1007/s00262-014-1591-2
Vence, 2007, Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma, Proc Natl Acad Sci U S A, 104, 20884, 10.1073/pnas.0710557105
Chiang, 2013, A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside, Clin Cancer Res, 19, 4801, 10.1158/1078-0432.CCR-13-1185
Takeshima, 2010, Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy, Cancer Res, 70, 2697, 10.1158/0008-5472.CAN-09-2982
Karyampudi, 2014, Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody, Cancer Res, 74, 2974, 10.1158/0008-5472.CAN-13-2564